Fig. 4
From: Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA
Antibiofilm effects of AKBA. (A) Biofilm inhibition activity of AKBA determined by crystal violet staining. (B) Biofilm eradication activity of AKBA determined by crystal violet staining. (C) Biofilm inhibition visualization by SYTO9/PI staining. (D) Fluorescence intensity quantitation of (C). (E) Biofilm eradication visualization by SYTO9/PI staining. (F) Fluorescence intensity quantitation of (E). The biofilm was stained with SYTO9/PI fluorescent probes. SYTO9 (green) and PI (red) were indicated viable cells and dead cells, respectively. (G) Persister killing activity of AKBA determined by time-killing assay. VAN/CIP/DAP/GEN at the concentration of ten-fold of MIC were used as controls